| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4257236 | Transplantation Proceedings | 2010 | 4 Pages |
Abstract
IgA nephropathy is the most frequently occurring glomerulonephritis in the developed world. It is treated in the terminal phase via dialysis and transplantation. Posttransplantation recurrence is common, but evolves slowly. Herein, recovery of native kidney function 10 years after transplantation in a patient with IgA glomerulonephritis is described, and the potential effect of immunosuppression therapy, in particular with mycophenolate mofetil, is discussed.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
P. Hidalgo, T. Jiménez, L. Blanca, C. Cobelo, D. Burgos, I. Garcia, D. Hernández,